Form 4: Y-mAbs Therapeutics Executive Thomas Gad Sells Shares

Chief Business Officer Thomas Gad sold 70,000 shares of Y-mAbs Therapeutics (YMAB) common stock in two days.

Summary

• Thomas Gad, Chief Business Officer of Y-mAbs Therapeutics, sold 35,000 shares of common stock on June 10, 2024, at a weighted average price of $12.03.
• He then sold another 35,000 shares on June 11, 2024, at a weighted average price of $12.00.
• Following these transactions, Gad directly owns 158,700 shares and indirectly owns 162,681 shares through GAD Enterprises LLC and 60,000 shares through his children.
• The sales were executed in multiple trades at prices ranging from $12.00 to $12.12 on June 10 and $12.00 to $12.02 on June 11.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative as it reflects an insider selling shares, which could be interpreted as a lack of confidence, but could also be for personal financial reasons.

Industry Context

Insider sales are a common occurrence, but investors often monitor them closely to gauge executive sentiment about the company's prospects.

Stakeholder Impact

• Shareholders may react to the insider selling activity, potentially impacting the stock price.

Key Dates